1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9

Modify Date: 2024-04-06 16:21:10

1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9 Structure
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9 structure
Common Name 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9
CAS Number 326495-36-7 Molecular Weight 799.20
Density N/A Boiling Point N/A
Molecular Formula C44H79D9NO8P Melting Point N/A
MSDS N/A Flash Point N/A

 Use of 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9


1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9 is deuterium labeled 1,2-Distearoyl-sn-glycero-3-phosphorylcholine. 1,2-Distearoyl-sn-glycero-3-phosphorylcholine (1,2-Distearoyl-sn-glycero-3-PC; DSPC) is a cylindrical-shaped lipid. 1,2-Distearoyl-sn-glyc

 Names

Name 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9

  Biological Activity

Description 1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9 is deuterium labeled 1,2-Distearoyl-sn-glycero-3-phosphorylcholine. 1,2-Distearoyl-sn-glycero-3-phosphorylcholine (1,2-Distearoyl-sn-glycero-3-PC; DSPC) is a cylindrical-shaped lipid. 1,2-Distearoyl-sn-glyc
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[3].
References

[1]. Andrew D Miller. Delivery of RNAi therapeutics: work in progress. Expert Rev Med Devices. 2013 Nov;10(6):781-811.

[2]. Jayesh A Kulkarni, et al. On the role of helper lipids in lipid nanoparticle formulations of siRNA. Nanoscale. 2019 Nov 21;11(45):21733-21739.

[3]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

 Chemical & Physical Properties

Molecular Formula C44H79D9NO8P
Molecular Weight 799.20